|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 238,500.00 KRW | -0.42% |
|
+11.19% | +31.77% |
| 02-05 | CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5) | RE |
| 01-30 | Celltrion Launches Autoimmune Drug Aptozma in Europe | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 684B | 1,188B | 551B | 565B | 996B | |||||
Short Term Investments | 14.03B | 31.58B | 43.28B | 193B | 147B | |||||
Trading Asset Securities, Total | - | - | - | - | - | |||||
Total Cash And Short Term Investments | 698B | 1,220B | 594B | 757B | 1,143B | |||||
Accounts Receivable, Total | 1,252B | 1,101B | 1,622B | 939B | 1,215B | |||||
Other Receivables | 63.32B | 20.82B | 13.15B | 8.82B | 43.7B | |||||
Notes Receivable | 0 | 42.47B | 19.05B | 1.25B | 1.13B | |||||
Total Receivables | 1,316B | 1,164B | 1,654B | 949B | 1,260B | |||||
Inventory | 384B | 578B | 616B | 3,041B | 2,766B | |||||
Prepaid Expenses | 10.2B | 11.3B | 13.43B | 17.77B | 25.12B | |||||
Other Current Assets, Total | 108B | 101B | 51.46B | 115B | 390B | |||||
Total Current Assets | 2,516B | 3,074B | 2,930B | 4,881B | 5,584B | |||||
Gross Property Plant And Equipment | 1,359B | 1,423B | 1,544B | 1,816B | 1,710B | |||||
Accumulated Depreciation | -412B | -473B | -537B | -602B | -466B | |||||
Net Property Plant And Equipment | 946B | 950B | 1,007B | 1,215B | 1,245B | |||||
Long-term Investments | 79.37B | 89.28B | 118B | 135B | 161B | |||||
Goodwill | 62.92B | 33.01B | 35.16B | 11,475B | 11,914B | |||||
Other Intangibles, Total | 275B | 287B | 265B | 502B | 390B | |||||
Accounts Receivable Long-Term | 0 | 0 | 62.89B | 0 | 0 | |||||
Loans Receivable Long-Term | 0 | 0 | 131M | 131M | 247M | |||||
Deferred Tax Assets Long-Term | 28.99B | 28.62B | 32.18B | 63.47B | 194B | |||||
Deferred Charges Long-Term | 1,066B | 1,172B | 1,322B | 1,358B | 1,398B | |||||
Other Long-Term Assets, Total | 44.8B | 39.77B | 119B | 287B | 170B | |||||
Total Assets | 5,020B | 5,674B | 5,892B | 19,918B | 21,055B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 33.96B | 80.72B | 50.27B | 50.85B | 75.31B | |||||
Accrued Expenses, Total | 131B | 139B | 157B | 187B | 150B | |||||
Short-term Borrowings | 437B | 512B | 554B | 1,608B | 1,989B | |||||
Current Portion of Long-Term Debt | 132B | 54.48B | 81.43B | 168B | 86.2B | |||||
Current Portion of Leases | 2.42B | 3.01B | 2.73B | 8.17B | 11.67B | |||||
Current Income Taxes Payable | 100B | 180B | 88.7B | 57.04B | 218B | |||||
Unearned Revenue Current, Total | 3.43B | 3.58B | 6.77B | 21.71B | 18.18B | |||||
Other Current Liabilities | 216B | 238B | 353B | 370B | 638B | |||||
Total Current Liabilities | 1,057B | 1,210B | 1,294B | 2,471B | 3,187B | |||||
Long-Term Debt | 200B | 170B | 152B | 99.13B | 86.6B | |||||
Long-Term Leases | 3.09B | 4.37B | 2.89B | 7.98B | 19.09B | |||||
Unearned Revenue Non Current | 31.25B | 28.23B | 23.01B | 77.4B | 73.49B | |||||
Pension & Other Post Retirement Benefits | - | - | 3.35B | - | - | |||||
Deferred Tax Liability Non Current | 86.21B | 21.58B | 1.11B | 120B | 99.26B | |||||
Other Non Current Liabilities | 215B | 189B | 141B | 17.1B | 9.6B | |||||
Total Liabilities | 1,593B | 1,624B | 1,617B | 2,792B | 3,475B | |||||
Common Stock, Total | 135B | 138B | 141B | 220B | 221B | |||||
Additional Paid In Capital | 828B | 856B | 871B | 14,790B | 14,828B | |||||
Retained Earnings | 2,475B | 3,052B | 3,485B | 3,964B | 3,744B | |||||
Treasury Stock | -192B | -226B | -502B | -2,204B | -2,108B | |||||
Comprehensive Income and Other | 61.49B | 96.23B | 144B | 211B | 754B | |||||
Total Common Equity | 3,308B | 3,917B | 4,139B | 16,981B | 17,439B | |||||
Minority Interest | 120B | 133B | 135B | 145B | 141B | |||||
Total Equity | 3,428B | 4,050B | 4,274B | 17,126B | 17,580B | |||||
Total Liabilities And Equity | 5,020B | 5,674B | 5,892B | 19,918B | 21,055B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 158M | 158M | 156M | 226M | 224M | |||||
ECS Total Common Shares Outstanding | 158M | 158M | 156M | 226M | 224M | |||||
Book Value / Share | 20.92K | 24.75K | 26.45K | 75.05K | 77.9K | |||||
Tangible Book Value | 2,970B | 3,598B | 3,839B | 5,003B | 5,135B | |||||
Tangible Book Value Per Share | 18.79K | 22.73K | 24.53K | 22.11K | 22.94K | |||||
Total Debt | 774B | 744B | 792B | 1,890B | 2,193B | |||||
Net Debt | 76.07B | -476B | 198B | 1,133B | 1,050B | |||||
Debt Equivalent Oper. Leases | 2.23B | 2.69B | 2.76B | 2.96B | - | |||||
Minority Interest, Total (Incl. Fin. Div) | 120B | 133B | 135B | 145B | 141B | |||||
Equity Method Investments, Total | 48.03B | 64.84B | 88.54B | 105B | 112B | |||||
Account Code - Inventory Valuation | - | - | - | - | - | |||||
Inventories - Raw Materials, Total | 187B | 245B | 295B | 279B | 330B | |||||
Inventories - Work In Process, Total | 26.62B | 39.7B | 48.31B | 78.63B | 103B | |||||
Inventories - Finished Goods, Total | 195B | 359B | 365B | 2,727B | 2,386B | |||||
Inventories - Others | 904M | 2.2B | 11.51B | 10.2B | 13.37B | |||||
Land - (BS) | 302B | 302B | 302B | 302B | 302B | |||||
Buildings, Total | 372B | 373B | 373B | 601B | 601B | |||||
Machinery, Total | 630B | 684B | 700B | 723B | 724B | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 1.07B | 1.36B | 1.53B | 313M | 2.48B |
- Stock Market
- Equities
- A068270 Stock
- Financials Celltrion, Inc.
- Balance Sheet
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















